Education
About Us
Working with TipRanks
Follow Us
Impedimed Limited (IPDQF)
:IPDQF
IPDQF Stock Chart & Stats
$0.02
<$0.01(23.84%)
At close: 4:00 PM EST
$0.02
<$0.01(23.84%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.05
Previous CloseN/A
Volume1.78K
Average Volume (3M)5.35K
Market Cap
$48.43M
Enterprise ValueN/A
Total Cash (Recent Filing)$17.69M
Total Debt (Recent Filing)$1.05M
Price to Earnings (P/E)―
Beta2.85
Next Earnings
Feb 20, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,037,429,300
10 Day Avg. Volume16,058
30 Day Avg. Volume5,352
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)3.45
Price to Sales (P/S)5.55
P/FCF Ratio-4.52
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$0.06Price Target Upside200.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Impedimed Limited News
IPDQF FAQ
What was Impedimed Limited’s price range in the past 12 months?
Impedimed Limited lowest stock price was <$0.01 and its highest was $0.05 in the past 12 months.
What is Impedimed Limited’s market cap?
Impedimed Limited’s market cap is $48.43M.
When is Impedimed Limited’s upcoming earnings report date?
Impedimed Limited’s upcoming earnings report date is Feb 20, 2026 which is in 63 days.
How were Impedimed Limited’s earnings last quarter?
Currently, no data Available
Is Impedimed Limited overvalued?
According to Wall Street analysts Impedimed Limited’s price is currently Undervalued.
Does Impedimed Limited pay dividends?
Impedimed Limited does not currently pay dividends.
What is Impedimed Limited’s EPS estimate?
Impedimed Limited’s EPS estimate is 0.
How many shares outstanding does Impedimed Limited have?
Impedimed Limited has 2,037,429,300 shares outstanding.
What happened to Impedimed Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Impedimed Limited?
Currently, no hedge funds are holding shares in IPDQF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Impedimed Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$0.06 (200.00% Upside)
$0.06 (200.00% Upside)
Blogger Sentiment
Bullish
IPDQF Sentiment 70%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.25%
12-Months-Change
Fundamentals
Return on Equity
-74.00%
Trailing 12-Months
Asset Growth
-12.99%
Trailing 12-Months
Company Description
Impedimed Limited
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
IPDQF Company Deck
IPDQF Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed sentiment with significant achievements in reimbursement coverage and revenue growth. However, these positives were balanced by challenges in U.S. sales, cash flow concerns, and impacts from currency fluctuations.View all IPDQF earnings summariesIPDQF Stock 12 Month Forecast
Average Price Target
$0.06
▲(200.00% Upside)
Technical Analysis
Nova Eye Medical
―
Compumedics Limited
―
Cyclopharm Limited
―
Micro-X Ltd.
―
EMvision Medical Devices Ltd.
―
Ownership Overview
0.64% Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.35% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---